Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0AQ3H
|
||||
Former ID |
DIB002474
|
||||
Drug Name |
PF-610355
|
||||
Synonyms |
PF-00610355; Beta 2 adrenoceptor agonist (asthma), Pfizer
|
||||
Indication | Asthma; Chronic obstructive pulmonary disease [ICD9: 490-492, 493, 494-496; ICD10:J40-J44, J47, J45] | Discontinued in Phase 2 | [548443] | ||
Company |
Pfizer Inc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1(cccc(c1)CC(=O)NCc1cc(ccc1)c1ccc(cc1)O)CC(NC[C@@H](c1<br />ccc(c(c1)NS(=O)(=O)C)O)O)(C)C
|
||||
Target and Pathway | |||||
Target(s) | Beta-2 adrenergic receptor | Target Info | Agonist | [531136] | |
NetPath Pathway | TCR Signaling Pathway | ||||
Pathway Interaction Database | Arf6 trafficking events | ||||
Arf6 signaling events | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.